Phenotyping immune sensitization reveals pattern-based association with post-lung transplant complications

Area of Science:

• Immunology
• Transplantation Science
• Pulmonary Medicine

Background:

• Immune sensitization is a key factor in adverse lung transplant outcomes, including chronic lung allograft dysfunction (CLAD) and reduced survival.
• Previous research has analyzed individual immune markers (PRA, DSA, ACR, AMR) in isolation, leaving a gap in understanding their combined effects.
• Understanding synergistic and overlapping immune injury patterns is crucial for improving post-lung transplant care.

Purpose of the Study:

• To define immune sensitization phenotypes based on perioperative immune injury patterns.
• To evaluate the association of these phenotypes with post-transplant lung function (FEV1), CLAD risk, and survival in adult lung transplant recipients.
• To explore the impact of longitudinal immune injury patterns on transplant outcomes.

Main Methods:

• Retrospective cohort study of 502 adult lung transplant recipients.
• Classification of patients into 5 immune sensitization phenotypes: non-sensitized, pre-transplant humoral, post-transplant humoral, cellular-mediated, and mixed sensitization.
• Comparison of phenotypes regarding initial post-transplant FEV1, CLAD onset, and overall survival.

Main Results:

• The mixed sensitization phenotype was associated with poorer post-transplant lung function and increased mortality.
• While CLAD onset showed a similar trend, it did not reach statistical significance across all phenotypes.
• Within the mixed group, antibody-mediated rejection (AMR) specifically correlated with adverse lung outcomes.

Conclusions:

• Immune sensitization should be viewed as dynamic, overlapping patterns of immune injury over time post-transplant.
• The developed phenotypes offer a framework for future research into post-transplant surveillance and personalized immunomodulatory treatments.
• Recognizing distinct immune injury patterns can guide strategies to mitigate adverse lung transplant outcomes.